• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无定形药物的结晶倾向:动力学和热力学。

Crystallization Propensity of Amorphous Pharmaceuticals: Kinetics and Thermodynamics.

机构信息

Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States.

出版信息

Mol Pharm. 2022 Feb 7;19(2):472-483. doi: 10.1021/acs.molpharmaceut.1c00839. Epub 2022 Jan 3.

DOI:10.1021/acs.molpharmaceut.1c00839
PMID:34979803
Abstract

Four model compounds, nifedipine, indomethacin, felodipine, and ketoconazole, all with nearly identical glass transition temperatures, were chosen to study the effects of thermodynamics and molecular mobility on their crystallization propensities. The time and temperature dependence of the crystallization induction time of each compound was determined by differential scanning calorimetry (DSC) and enabled the generation of their time-temperature-transformation (TTT) diagrams. The relaxation times (τ) were measured by dielectric spectroscopy, and the Gibbs free energy (Δ) and entropy (Δ) difference between the crystalline and amorphous states were obtained by DSC. The temperature dependence of the crystallization induction time (τ()) is a function of the thermodynamic activation barrier and the frequency of "attempted jumps" (1/τ()) to overcome the barrier. Even though the four model compounds exhibited very similar molecular mobility (relaxation time) over a wide range of temperatures, their crystallization propensities were very different. The observed difference in crystallization propensity was explained in terms of the difference in the thermodynamic barrier, and it is correlated to the empirical relation (Δ)/Δ.

摘要

选择了四种模型化合物,硝苯地平、吲哚美辛、非洛地平、酮康唑,它们的玻璃化转变温度几乎相同,以研究热力学和分子迁移率对它们结晶倾向的影响。通过差示扫描量热法(DSC)确定了每种化合物结晶诱导时间的时间和温度依赖性,从而生成了它们的时-温转变(TTT)图。通过介电谱测量了弛豫时间(τ),并通过 DSC 获得了晶态和非晶态之间的吉布斯自由能(Δ)和熵(Δ)差。结晶诱导时间(τ()的温度依赖性是热力学激活势垒和克服势垒的“尝试跳跃”(1/τ())频率的函数。尽管这四种模型化合物在很宽的温度范围内表现出非常相似的分子迁移率(弛豫时间),但它们的结晶倾向却非常不同。用热力学势垒的差异来解释观察到的结晶倾向差异,并将其与经验关系(Δ)/Δ相关联。

相似文献

1
Crystallization Propensity of Amorphous Pharmaceuticals: Kinetics and Thermodynamics.无定形药物的结晶倾向:动力学和热力学。
Mol Pharm. 2022 Feb 7;19(2):472-483. doi: 10.1021/acs.molpharmaceut.1c00839. Epub 2022 Jan 3.
2
Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.非晶态药物分子流动性及等温结晶动力学的介电研究
J Pharm Sci. 2004 Jan;93(1):218-33. doi: 10.1002/jps.10520.
3
Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.根据实验弛豫时间预测结晶开始——从高于玻璃化转变温度到低于玻璃化转变温度的分子流动性的关联。
Pharm Res. 2006 Oct;23(10):2277-90. doi: 10.1007/s11095-006-9079-1. Epub 2006 Aug 24.
4
A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses.两种药用玻璃物理稳定性的热力学和分子流动性贡献的量热研究
J Pharm Sci. 2007 Jan;96(1):71-83. doi: 10.1002/jps.20633.
5
Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility.非晶态药物的物理稳定性:构型热力学量和分子流动性的重要性。
J Pharm Sci. 2002 Aug;91(8):1863-72. doi: 10.1002/jps.10169.
6
Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.基于分子迁移率估算聚(乙烯基吡咯烷酮)固体分散体中无定形硝苯地平和苯巴比妥的结晶速率
J Pharm Sci. 2004 Feb;93(2):384-91. doi: 10.1002/jps.10526.
7
Isothermal Crystallization Monitoring and Time-Temperature-Transformation of Amorphous GDC-0276: Differential Scanning Calorimetric and Rheological Measurements.等温结晶监测和非晶态 GDC-0276 的时间-温度-转变:差示扫描量热法和流变学测量。
Mol Pharm. 2021 Jan 4;18(1):158-173. doi: 10.1021/acs.molpharmaceut.0c00776. Epub 2020 Dec 1.
8
A comparison of the physical stability of amorphous felodipine and nifedipine systems.非晶态非洛地平和硝苯地平体系的物理稳定性比较。
Pharm Res. 2006 Oct;23(10):2306-16. doi: 10.1007/s11095-006-9047-9. Epub 2006 Aug 23.
9
Determination of Fragility in Organic Small Molecular Glass Forming Liquids: Comparison of Calorimetric and Spectroscopic Data and Commentary on Pharmaceutical Importance.有机小分子玻璃形成液体的脆性测定:热分析和光谱数据的比较及对药物重要性的评论。
Mol Pharm. 2018 Mar 5;15(3):1248-1257. doi: 10.1021/acs.molpharmaceut.7b01068. Epub 2018 Feb 7.
10
Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach.结构弛豫过程中分子迁移率的时间依赖性及其对有机非晶态固体的影响:基于量热法的研究
Pharm Res. 2006 Aug;23(8):1906-17. doi: 10.1007/s11095-006-9008-3.

引用本文的文献

1
Calorimetric Monitoring of the Sub-T Crystal Growth in Molecular Glasses: The Case of Amorphous Nifedipine.分子玻璃中亚稳 T 晶体生长的量热法监测:以非晶态硝苯地平为例。
Molecules. 2025 Apr 9;30(8):1679. doi: 10.3390/molecules30081679.
2
Mechanistic Investigation into Crystallization of Hydrated Co-Amorphous Systems of Flurbiprofen and Lidocaine.氟比洛芬和利多卡因水合共无定形体系结晶的机理研究。
Pharmaceutics. 2025 Jan 30;17(2):175. doi: 10.3390/pharmaceutics17020175.
3
The Implications of Drug-Polymer Interactions on the Physical Stability of Amorphous Solid Dispersions.
药物-聚合物相互作用对无定形固体分散体物理稳定性的影响。
Pharm Res. 2023 Dec;40(12):2963-2981. doi: 10.1007/s11095-023-03547-4. Epub 2023 Jun 30.
4
Indomethacin: Effect of Diffusionless Crystal Growth on Thermal Stability during Long-Term Storage.吲哚美辛:无扩散晶体生长对长期储存过程热稳定性的影响。
Molecules. 2023 Feb 6;28(4):1568. doi: 10.3390/molecules28041568.